Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the ...
They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard ...
Humacyte has priced the product at $29,500 per unit. This is more expensive than the synthetic vessels already on the market.
Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...
Chemists at Emory University have invented a reaction to streamline the total synthesis of a compound, phaeocaulisin A, ...
A joint research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Science at the University of Hong Kong has uncovered an unexpected interaction between chemotherapeutic agents and a ...
Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...
4d
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback